期刊文献+

单鞘管法射频消融治疗阵发性心房颤动的可行性分析 被引量:3

原文传递
导出
摘要 目的:探讨应用单鞘管方法对阵发性心房颤动患者行导管射频消融术的可行性。方法:行射频消融治疗阵发性心房颤动患者28例随机分为A组10例,B组18例。A组行双鞘管2次穿刺房间隔置入长鞘消融,B组行单次穿刺置鞘消融。比较2组手术时间、X线透视时间、肺静脉隔离率、围术期并发症发生率。结果:A组手术时间、X线透视时间分别为135~240(168±34)min,19~38(22±6)min,B组分别为115~270(181±46)min,21~42(29±11)min,2组比较差异无统计学意义(P〉0.05)。A、B组各有1例患者未完成肺静脉隔离,2组比较差异无统计学意义(P〉0.05)。2组围术期均未出现并发症。结论:单鞘管法射频消融治疗阵发性心房颤动与常规双鞘管方法同样安全、有效。
出处 《中华实用诊断与治疗杂志》 2011年第5期474-475,共2页 Journal of Chinese Practical Diagnosis and Therapy
  • 相关文献

参考文献5

  • 1杜昕,马长生.心房颤动的再认识(一)[J].中国心血管病研究,2005,3(10):725-727. 被引量:33
  • 2Verma A, Kilicaslan F, Pisano E, et al. Response of atrial fibrillation to puhnonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction [ J]. Circulation, 2005,112(8) : 627-635.
  • 3Haissaguerre M, Sanders P, Hocini M, et al. Pulmonary veins in the substrate for atrial fibrillation: the "venous wave" hypothesis[J]. J Am Coll Cardiol, 2004,43 (12) : 2290-2292.
  • 4Ouyang F, Bansch D, Ernst S, et al. Complete isolation of left atrium surrounding the pulmonary veins; new insights from the double-Lasso technique in paroxysmal atrial fibrillation [J]. Circulation, 2004,110(15) : 2090-2096.
  • 5董建增,马长生,刘兴鹏,龙德勇,喻荣辉,汤日波,宁曼.单导管隔离肺静脉前庭的方法学评价[J].中国介入心脏病学杂志,2008,16(3):141-144. 被引量:5

二级参考文献13

  • 1马长生,董建增,王京,刘兴鹏,龙德勇,刘小青,储慧民,胡福莉.三维标测与肺静脉环状标测联合应用于心房颤动导管消融术[J].中国介入心脏病学杂志,2004,12(4):197-199. 被引量:4
  • 2董建增,马长生,刘兴鹏,龙德勇,刘小青.对射频消融术后心房颤动复发患者在三维标测系统指导下再次手术治疗[J].中国介入心脏病学杂志,2005,13(4):215-218. 被引量:4
  • 3Marrouche NF, Dresing T, Cole C, et al. Circular mapping and ablation of the pulmonary vein for treatment of atrial fibrillation : impact of different catheter technologies. J Am Coll Cardiol, 2002, 40 : 464-474.
  • 4Oral H, Chugh A, Good E, et al. A tailored approach to catheter ablation of paroxysmal atrial fibrillation. Circulation, 2006,113 : 1824-1831.
  • 5Liu X, Dong J, Mavrakis HE, et al. Achievement of pulmonary vein isolation in patients undergoing circumferential pulmonary vein ablation: a randomized comparison between two different isolation approaches. J Cardiovasc Electrophysiol, 2006,17 : 1263- 1270.
  • 6Ahmed J, Sohal S, Malchano ZJ, et al. Three-dimensional analysis of pulmonary venous ostial and antral anatomy: implications for balloon catheter-based pulmonary vein isolation. J Cardiovasc Electrophysiol, 2006,17 : 251-255.
  • 7Kato R, Lickfett L, Meininger G, et al. Pulmonary vein anatomy in patients undergoing catheter. Circulation, 2003, 107 : 2004- 2010.
  • 8Mantovan R, Verlato R, Calzolari V, et al. Comparison between anatomical and integrated approaches to atrial fibrillation ablation : adjunctive role of electrical pulmonary vein disconnection. J Cardiovasc Electrophysiol,2005,16 : 1293-1297.
  • 9Lemola K, Oral H, Chugh A, et al. Pulmonary vein isolation as an end point for left atrial circumferential ablation of atrial fibrillation. J Am Coll Cardiol, 2005, 46: 1060-1066.
  • 10Oral H, Veerareddy S, Good E, et al. Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation. J Cardiovasc Electrophysiol,2004, 15: 920-924.

共引文献36

同被引文献32

  • 1Go A S, Hylek E M, Phillips K A, et al. Prevalence of diagnosed atri- al fibrillation in adults: national implications for rhythm management and stroke prevention: the An Ticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study [ J]. JAMA, 2001, 285 (18): 2370- 2375.
  • 2Carom A J, Kirchhof P, Lip G Y, et al. Guidelines for the manage- ment of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology ( ESC ) [ J ]. Eur Heart J, 2010, 31(19): 2369-2429.
  • 3Jais P, Cauchemez B, Macle L, et al. Catheter ablation versus antiar- rhythmic drugs for atrial fibrillation: the A4 study [ J ]. Circulation, 2008, 118(24) : 2498 -2505.
  • 4Shin S Y, Yong H S, Na J O, et al. A simplified method to determine left atrial volume and transport function using multi-slice computed tomography in patients with atrial fibrillation : comparison with transtho- racic echocardiography[ J ]. Int J Cardiovasc Imaging, 2012, 28 (5) : 1205 - 1216.
  • 5Fan J, Cao H, Su L, et al. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients under- going pulmonary vein isolation [ J ]. J Interv Card Electrophysiol, 2012, 33(1) : 93 -100.
  • 6Patel P, Dokainish H, Tsai P, et al. Update on the association of in- flammation and atrial fibrillation [ J ]. J Cardiovasc Electrophysiol, 2010, 21(9) : 1064 -1070.
  • 7Ridker P M, Hennekens C H, Buring J E, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[ J]. N Engl J Med, 2000, 342(12) : 836 -843.
  • 8Kaptoge S, Di-Angelantonio E, Lowe G, et al. C-reactive protein con- centration and risk of coronary heart disease, stroke, and mortality : an individual participant meta-analysis [J].Lancet, 2010, 375 (9709) : 132 - 140.
  • 9Jiang Z, Dai L, Song Z, et al. Association Between C-Reactive Pro- tein and Atrial Fibrillation Recurrence After Catheter Ablation : A Me- ta-analysis[J]. Clin Cardiol, 2013, 36(9) : 548 -4554.
  • 10Dernellis J, Panaretou M. Relationship between C-reactive protein concentrations during glueoeorticoid therapy and recurrent atrial fibril- lation[J]. Eur Heart J, 2004, 25(13) : 1100 - 1107.

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部